The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.

The concept of a major research institute on this site arose from the thinking of notable Queensland clinicians including Professor Bryan Emmerson and Dr John Golledge, and the vision was conceived and brought to fruition by the clinicians and scientists of the four institutions who were its founding partners; The University of Queensland, Queensland University of Technology, Mater Medical Research Institute and Queensland Health.

Translational Research - Our Work

Translational Research aims to convert scientific innovations into health gains. It involves a multidisciplinary approach, early involvement with a commercial partner and a focus on positive outcomes for patients, the community and world health.

The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist. While traditionally, clinicians and researchers worked separately, this improved method ensures patient needs are priority and that teams share knowledge which multiplies with every collaboration. These teams also create a feedback loop which is essential to the translational pathway. With the clinician and scientist working side by side with the patient, results are obvious immediately rather than via long reports which take time to read and interpret.

Several translational research projects are underway at TRI, including the Gardasil HPV Vaccine, Spectroscopy for high risk breast cancer, and Theranostic Development For Prostate Cancer

> Learn more about our work


The Translational Research Institute (TRI) is a partnership of four medical research institutions:

  • Queensland Health's Princess Alexandra Hospital (PAH);
  • The University of Queensland (UQ);
  • Queensland University of Technology (QUT);
  • and Mater Research.

Entities at TRI

TRI is honoured to be the home of some leading companies working in the life sciences sector and who choose to licence space at TRI's world-class facilities. For further details on these companies please vist the Industry@TRI page


Queensland University of Technology

Queensland University of Technology (QUT) is a leading Australian university with a focus on world-class research and education. TRI's partner, expert researchers at work across disciplines of health, science, technology and built environment and engineering to integrate their expertise in the areas of prevention, mind and body health, and recovery.

The University of Queensland - Frazer INSTITUTE

A member of the Group of Eight Universities Australia, University of Queensland (UQ) was the first tertiary education institute in Queensland. The Frazer Institute is a modern research facility where clinical and basic science converge in the translational research of cancer, immunology and genomic medicine. Based at the Translational Research Institute beside the Princess Alexandra Hospital, the Frazer Institute has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields.

The University of Queensland FACULTY of Medicine

The University of Queensland's Faculty of Medicine combines two research intensive schools, medical education, and five hospital-based institutes and centres. In doing so, it achieves a broad coverage of the ‘translational pipeline' linking the pre-clinical and clinical sciences with population and global health.

As the custodians of more than 4,000 future medical and biomedical health clinicians and researchers, the Faculty of Medicine is driven, dedicated, and duty-bound to ensure the next generation of doctors, scientists, and health professionals is equipped with the tools to achieve their vision.

Within the Faculty are teachers; researchers; students and support staff. Combined, these health professionals are united in the quest to make a global difference to health outcomes.

Princess Alexandra Hospital

The Princess Alexandra Hospital (PAH) encourages its clinicians to partner with academic researchers at TRI. With an enviable legacy and one of the state’s largest hospitals, PAH is renowned as being Queensland’s foremost teaching and research hospital.  The PAH has responsibility for the management of the Queensland Liver Transplant Service, Queensland Eye Bank and the Queensland Bone Bank, as well as housing one of the major Pathology Queensland services.

Mater Research

Nestled within the Mater's hospitals at South Brisbane, Mater Reseach is driven by a 'bench to bedside' philosophy, where leading scientists work alongside doctors to turn basic scientific discovery into better treatment for patients. This world-class research has already contributed to significant advances in patient care and currently runs research programs in cancer, immunology, transplantation, mental health, pregnancy-related disorders, growth and development, diabetes and obesity - with high-profile research being undertaken in flood and disaster recovery, preventing stillbirths and improving our understanding and treatment of cancer.